Daan Gene Co (SZSE:002030) ROCE % : -23.44% (As of Dec. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Daan Gene Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Daan Gene Co's annualized ROCE % for the quarter that ended in Dec. 2024 was -23.44%.

Daan Gene Co ROCE % Historical Data

The historical data trend for Daan Gene Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daan Gene Co ROCE % Chart

Daan Gene Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

82.07

66.08

64.61

1.17

-12.08

Daan Gene Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROCE %	Get a 7-Day Free Trial															-13.17	-18.98	-1.79	-4.11	-23.44

Daan Gene Co ROCE % Calculation

Daan Gene Co's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	-1061.419	/	( ( (11017.917 - 1721.088)	+	(9576.916 - 1293.747) )	/ 2 )
	=	-1061.419	/	( (9296.829	+	8283.169)	/ 2 )
	=	-1061.419	/	8789.999
	=	-12.08 %

Daan Gene Co's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	-1997.136	/	( ( (9983.928 - 1230.058)	+	(9576.916 - 1293.747) )	/ 2 )
	=	-1997.136	/	( ( 8753.87	+	8283.169 )	/ 2 )
	=	-1997.136	/	8518.5195
	=	-23.44 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

Daan Gene Co (SZSE:002030) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Daan Gene Co ROCE % Related Terms

Thank you for viewing the detailed overview of Daan Gene Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Daan Gene Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Daan Gene Co Ltd (SZSE:002030) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.19 Xiangshan Road, Science Park, High & New Technology Development District, Guangdong, Guangzhou, CHN, 510665

Website

https://www.daangene.com

Daan Gene Co Ltd is a high-tech enterprise-oriented in molecular diagnostic techniques. It is primarily committed to research and development, production, and service of in-vitro diagnostic products, including qPCR, Sequeacing, TRF, ELISA, and Liquid-Based Cytology diagnostic kits and equipment. Geographically, tahe group operates in China.

Executives

Zhou Xin Yu	Directors, executives
He Yun Shao	Director
Huang Ru Hui	Supervisors
Cheng Gang	Directors, executives
Xu Qing	Supervisors
He Li Xin	Supervisors

Daan Gene Co Headlines

No Headlines